You have 9 free searches left this month | for more free features.

Thiotepa

Showing 1 - 25 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory (R/R) Primary CNS Lymphoma Trial in Nanjing (thiotepa combined with pomalidomide)

Recruiting
  • Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
  • thiotepa combined with pomalidomide
  • Nanjing, Jiangsu, China
    Jiangsu Province People's Hospital.
Jun 27, 2023

HLH Trial in Beijing (Thiotepa)

Recruiting
  • HLH
  • Thiotepa
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 10, 2023

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

    Recruiting
    • Cytarabine+Thiotepa + Fludarabine + Busulfan
    • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • cytarabine+thiotepa+ fludarabine + busulfan
    • Hangzhou, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 26, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Reduced-Intensity Conditioning Regimen
    • Myeloablative Conditioning Regimen
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Jan 4, 2023

    Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

    Active, not recruiting
    • Hematologic Malignancies
    • +7 more
    • Thiotepa
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

    Recruiting
    • Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer Center, Case Comprehensive C
    Jan 24, 2022

    Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

    Recruiting
    • Stem Cell Transplant Complications
    • +4 more
    • Radiation
    • +7 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

    Recruiting
    • Sickle Cell Disease
    • Bone Marrow Transplant (BMT)
    • +7 more
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Sep 13, 2022

    Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

    Recruiting
    • Neuroblastoma
    • Thiotepa
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

    Active, not recruiting
    • Leukemia
    • +3 more
    • Palifermin
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)

    Not yet recruiting
    • Refractory and Relapsed Primary CNS Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Medical Oncology, Sun Yat-sen University Cancer Ce
    Aug 19, 2021

    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Leukemia, Lymphocytic, Acute
    • Total Body Irradiation (TBI)
    • +5 more
    • Miami, Florida
      Baptist Health South Florida/Miami Cancer Institute
    Nov 28, 2022

    Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

    Completed
    • Leukemia
    • +4 more
    • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 10, 2022

    CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

    Active, not recruiting
    • CNS Lymphoma
    • +2 more
    • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
    • Basking Ridge, New Jersey
    • +2 more
    Jan 27, 2023

    Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

    Completed
    • Leukemia
    • Lymphoma
    • Total Lymphoid Irradiation
    • +10 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 28, 2022

    Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,

    Recruiting
    • Breast Cancer
    • carboplatin, thiotepa, and cyclophosphamide
    • chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
    • Amsterdam, Netherlands
      NKI-AVL
    Mar 21, 2022

    Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

    Withdrawn
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Sep 26, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and

    Recruiting
    • Sickle Cell Disease
    • hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
    • hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    May 5, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Personalized rATG (P-rATG)
    • +7 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 31, 2022

    Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,

    Recruiting
    • Bone Marrow Failure Syndrome
    • +15 more
    • Thiotepa--single daily dose
    • Thiotepa--escalated dose
    • Gainesville, Florida
      UF Health Shands Children's Hospital
    Jul 8, 2021

    Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

    Recruiting
    • Ewing's Family Tumors
    • +11 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 11, 2022